Abcellera Biologics Inc.
ABCL
Revenue
5.05M
▼-1.46M▼-22.41%
3 Months ChangeAssets
1.36B
▼-32.28M▼-2.32%
3 Months ChangeLiabilities
304.47M
▼-10.27M▼-3.26%
3 Months ChangeFree Cash Flow
-65.85M
▼-6.80M▼-11.52%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-06
Form 10-Q
ID: 0001628280-24-035248
2024-08-06
Form 8-K
ID: 0001628280-24-035229
2024-06-13
Form 8-K
ID: 0001628280-24-028097
2024-05-07
Form 10-Q
ID: 0001628280-24-021159
2024-05-07
Form 8-K
ID: 0001628280-24-021115
2024-02-23
Form 8-K
ID: 0001703057-24-000024
2024-02-20
Form 8-K
ID: 0001703057-24-000017
2023-11-28
Form 8-K
ID: 0001703057-23-000047
2023-11-02
Form 10-Q
ID: 0001703057-23-000040
2023-11-02
Form 8-K
ID: 0001703057-23-000038